STRUCTURE OF RUSSIAN PUBLICATIONS IN CLINICAL IMMUNOLOGY AND ALLERGOLOGY (JOURNAL ARTICLES, CLINICAL TRIALS, META-ANALYSES AND PRACTICE GUIDELINES) IN COMPARISON WITH OTHER BRICS COUNTRIES IN 2008-2015
https://doi.org/10.15789/1563-0625-2018-1-7-18
Abstract
It is obvious that any evolving scientific medical field is a dynamic system that cannot stay at the stage of accumulation of primary information, and inevitably goes to the stages of clinical trials, generalization of information in meta-analyses and completes the study by creation of practical guidelines. The purpose of this study was a quantitative analysis of publicly available data in the field of clinical immunology in Russia during 2008-2015, identifying the ratios of clinical trials, meta-analyses, and practical guidelines, as well as evaluating the results by comparison with other BRICS countries. Study design was performed by retrospective bibliometric methods. It is revealed, that, in Russia, 16 clinical trials, 3 meta-analyses and 1 practice guideline were issued per 1000 original journal articles. Accordingly in the People’s Republic of China this ratios have made 34/25/4; in Federal Republic of Brazil, 42/87/7; in Republic of India, 76/58/34, and in Republic of Southern Africa, 134/43/36. Moreover, we have obtained evidence which suggests optimistic prospectives for scientific clinical immunology in Russia.
About the Authors
L. I. Lugacheva
Novosibirsk State University, Novosibirsk;
Institute of Economics and Industrial Engineering, Siberian Branch, Russian Academy of Sciences, Novosibirsk
Russian Federation
PhD (Economy), Associate Professor, Leading Research Associate, Department of Analysis and Forecasting in Sectoral Systems, Institute of Economics and Industrial Engineering, Siberian Branch, Russian Academy of Sciences; Associate Professor, Department of Economic Management, Novosibirsk State University, Novosibirsk
Russian Federation
PhD (Economy), Associate Professor, Leading Research Associate, Department of Analysis and Forecasting in Sectoral Systems, Institute of Economics and Industrial Engineering, Siberian Branch, Russian Academy of Sciences; Associate Professor, Department of Economic Management, Novosibirsk State University, Novosibirsk
M. I. Musatov
Novosibirsk State University, Novosibirsk;
Research Institute of Fundamental and Clinical Immunology, Novosibirsk
Russian Federation
PhD, MD (Medicine), Professor, Faculty of Fundamental Medicine, Novosibirsk State University; Research Associate, Research Institute of Fundamental and Clinical Immunology, Novosibirsk
Russian Federation
PhD, MD (Medicine), Professor, Faculty of Fundamental Medicine, Novosibirsk State University; Research Associate, Research Institute of Fundamental and Clinical Immunology, Novosibirsk
References
1. Ларионова М.В., Рахмангулов М.Р., Шелепов А.В., Сахаров А.Г. Формирование повестки дня для БРИКС в сфере здравоохранения // Вестник международных организаций, 2014. Т. 9, № 4. С. 102-125. [Larionova M.V., Rakhmangulov M.R., Shelepov A.V., Sakharov A.G. BRICS: Emergence of health agenda. Vestnik mezhdunarodnykh organizatsiy = International Organisations Research Journal, 2014, Vol. 9, no. 4, pp. 102-125. (In Russ.)]
2. Ширинский В.С., Старостина Н.М., Сенникова Ю.А., Ширинский И.В., Соловьева Н.Ю., Малышева О.А., Круглеева О.Л., Непомнящих В.М. Проблемы иммуностимулирующей терапии с позиций доказательной медицины // Медицинская иммунология, 2000. Т. 2, № 1. С. 17-24. [Shirinsky V.S., Starostina N.M., Sennikova Yu.A., Shirinsky I.V., Solovyova N.Yu., Malysheva O.A., Krugleyeva O.L., Nepomnyashchikh V.M. Immunostimulating drugs abilities from viewpoint of evidence based medicine. Meditsinskaya immunologiya = Medical Immunology (Russia), 2000, Vol. 2, no. 1, pp. 17-24. (In Russ.)]
3. Abramson J.H. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol. Perspect. Innov., 2011, Vol. 8, no. 1, p. 1.
4. Chan A.W., Tetzlaff J.M., Altman D.G., Laupacis A., Gøtzsche P.C., Krleža-Jerić K., Hróbjartsson A., Mann H., Dickersin K., Berlin J.A., Doré C.J., Parulekar W.R., Summerskill W.S.M., Groves T., Schulz K.F., Sox H.C., Rockhold F.W., Rennie D., Moher D. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Ann Intern. Med., 2013, Vol. 158, no. 3, pp. 200-207.
5. Krleža-Jerić K., Chan A.W., Dickersin K., Sim I., Grimshaw J., Gluud C. Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ, 2005, Vol. 330, no. 7497, pp. 956-958.
6. Krleža-Jerić K., Gabelica M., Banzi R., Krnić-Martinić M., Pulido B., Mahmić-Kaknjo M., Reveiz L., Šimić J., Utrobičić A., Hrgović I. IMPACT Observatory: tracking the evolution of clinical trial data sharing and research integrity. Biochemia Medica, 2016, Vol. 26, no. 3, pp. 308-317.
7. Sully B.G., Julious S.A., Nicholl J. A reinvestigation of recruitment to randomised, controlled, multicenter trials: a review of trials funded by two UK funding agencies. Trials, 2013, Vol. 14, p. 166.
Review
For citations:
Lugacheva L.I., Musatov M.I. STRUCTURE OF RUSSIAN PUBLICATIONS IN CLINICAL IMMUNOLOGY AND ALLERGOLOGY (JOURNAL ARTICLES, CLINICAL TRIALS, META-ANALYSES AND PRACTICE GUIDELINES) IN COMPARISON WITH OTHER BRICS COUNTRIES IN 2008-2015. Medical Immunology (Russia). 2018;20(1):7-18. (In Russ.) https://doi.org/10.15789/1563-0625-2018-1-7-18
Views:
858
Email this article 